In the preclinical mouse model of MLL-AF4+ infant acute lymphoblastic leukemia, I-BET151 downregulates the transcription of the BRD4, HOXA7/HOXA9, and RUNX1 gene network, which reduces the disease burden. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.